Outcomes of patients with IDH1-mutant relapsed or refractory acute myeloid leukemia receiving ivosidenib who proceeded to hematopoietic stem cell transplant

被引：10

作者：

DiNardo, Courtney D. ^{[1
]}

Stein, Eytan M. ^{[2
]}

Pigneux, Arnaud ^{[3
]}

Altman, Jessica K. ^{[4
]}

Collins, Robert ^{[5
]}

Erba, Harry P. ^{[6
]}

Watts, Justin M. ^{[7
]}

Uy, Geoffrey L. ^{[8
]}

Winkler, Thomas ^{[9
]}

Wang, Hongfang ^{[9
]}

Choe, Sung ^{[9
]}

Liu, Hua ^{[9
]}

Wu, Bin ^{[9
]}

Kapsalis, Stephanie M. ^{[9
]}

Roboz, Gail J. ^{[10
,11
]}

de Botton, Stephane ^{[12
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[3] CHU Bordeaux, Bordeaux, France

[4] Northwestern Univ, Chicago, IL 60611 USA

[5] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA

[6] Univ Alabama Birmingham, Birmingham, AL USA

[7] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA

[8] Washington Univ, Sch Med, St Louis, MO 63110 USA

[9] Agios Pharmaceut Inc, Cambridge, MA USA

[10] Weill Cornell Med, New York, NY USA

[11] New York Presbyterian Hosp, New York, NY USA

[12] Inst Gustave Roussy, Villejuif, France

来源：

LEUKEMIA | 2021年 / 35卷 / 11期

关键词：

AML;

D O I：

10.1038/s41375-021-01229-x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：3278 / 3281

页数：4

共 50 条

[1] Outcomes of patients with IDH1-mutant relapsed or refractory acute myeloid leukemia receiving ivosidenib who proceeded to hematopoietic stem cell transplant
Courtney D. DiNardo
Eytan M. Stein
Arnaud Pigneux
Jessica K. Altman
Robert Collins
Harry P. Erba
Justin M. Watts
Geoffrey L. Uy
Thomas Winkler
Hongfang Wang
Sung Choe
Hua Liu
Bin Wu
Stephanie M. Kapsalis
Gail J. Roboz
Stéphane de Botton
Leukemia, 2021, 35 : 3278 - 3281
[2] Ivosidenib (IVO) prior to hematopoietic cell transplant for patients with IDH1-mutant relapsed or refractory acute myeloid leukemia (R/R AML).
Dinardo, Courtney Denton
Stein, Eytan
Pigneux, Arnaud
Altman, Jessica K.
Collins, Robert
Erba, Harry Paul
Watts, Justin M.
Uy, Geoffrey L.
Kapsalis, Stephanie M.
Liu, Hua
Winkler, Thomas
Roboz, Gail J.
de Botton, Stephane
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[3] EXPOSURE-RESPONSE ANALYSIS OF IVOSIDENIB IN PATIENTS WITH IDH1-MUTANT RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA.
Le, K.
Kleijn, H. J.
Dai, D.
Fan, B.
Liu, H.
Attar, E. C.
Hickman, D.
Agresta, S. V.
Yang, H.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S85 - S85
[4] Ivosidenib (IVO) Prior to Hematopoietic Cell Transplant (HCT) for Patients with IDH1-Mutant Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) Who Cannot Tolerate Intensive Chemotherapy (IC)
DiNardo, Courtney D.
Stein, Eytan M.
Pigneux, Arnaud
Altman, Jessica K.
Collins, Robert
Erba, Harry P.
Watts, Justin M.
Uy, Geoffrey L.
Wu, Bin
Choe, Sung
Kapsalis, Stephanie M.
Liu, Hua
Winkler, Thomas
Roboz, Gail J.
de Botton, Stephane
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S197 - S198
[5] Molecular Mechanisms Mediating Relapse Following Ivosidenib Monotherapy in Patients with IDH1-Mutant Relapsed or Refractory Acute Myeloid Leukemia
Choe, Sung
Wang, Hongfang
DiNardo, Courtney D.
Stein, Eytan M.
De Botton, Stephane
Fathi, Amir T.
Tallman, Martin S.
Kantarjian, Hagop M.
Stone, Richard M.
Quek, Lynn
Konteatis, Zenon
Dang, Lenny
Zhang, Vickie
Liu, Hua
Attar, Eyal C.
Wu, Bin
BLOOD, 2019, 134
[6] Complex Polyclonal Resistance Mechanisms to Ivosidenib Monotherapy in IDH1-Mutant Relapsed or Refractory Acute Myeloid Leukemia Revealed By Single Cell Sequencing Analyses
Wang, Hongfang
Choe, Sung
DiNardo, Courtney D.
Stein, Eytan M.
de Botton, Stephane
Fathi, Amir T.
Tallman, Martin S.
Kantarjian, Hagop M.
Stone, Richard M.
Quek, Lynn
Zhang, Vickie
Liu, Hua
Attar, Eyal C.
Wu, Bin
BLOOD, 2019, 134
[7] Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia
Roboz, Gail J.
DiNardo, Courtney D.
Stein, Eytan M.
de Botton, Stephane
Mims, Alice S.
Prince, Gabrielle T.
Altman, Jessica K.
Arellano, Martha L.
Donnellan, Will
Erba, Harry P.
Mannis, Gabriel N.
Pollyea, Daniel A.
Stein, Anthony S.
Uy, Geoffrey L.
Watts, Justin M.
Fathi, Amir T.
Kantarjian, Hagop M.
Tallman, Martin S.
Choe, Sung
Dai, David
Fan, Bin
Wang, Hongfang
Zhang, Vickie
Yen, Katharine E.
Kapsalis, Stephanie M.
Hickman, Denice
Liu, Hua
Agresta, Samuel, V
Wu, Bin
Attar, Eyal C.
Stone, Richard M.
BLOOD, 2020, 135 (07) : 463 - 471
[8] Longitudinal Molecular Profiling in Patients with IDH1-Mutant Newly Diagnosed Acute Myeloid Leukemia Treated with Ivosidenib
Choe, Sung
Wang, Hongfang
Roboz, Gail J.
DiNardo, Courtney D.
Stein, Eytan M.
Mims, Alice S.
Prince, Gabrielle T.
Watts, Justin M.
Fan, Bin
Nejad, Parham
Zhang, Vickie
Liu, Hua
Attar, Eyal C.
Wu, Bin
Stone, Richard M.
BLOOD, 2020, 136
[9] Ivosidenib for the treatment of relapsed or refractory acute myeloid leukemia with an IDH1 mutation
Pasquier, Florence
Chahine, Claude
Marzac, Christophe
de Botton, Stephane
EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2020, 5 (06): : 429 - 438
[10] Ivosidenib (AG-120) in Mutant IDH1 Relapsed/Refractory Acute Myeloid Leukemia: Results of a Phase 1 Study
DiNardo, Courtney D.
Stein, Eytan M.
de Botton, Stephane
Roboz, Gail J.
Altman, Jessica K.
Mims, Alice S.
Swords, Ronan
Collins, Robert H.
Mannis, Gabriel N.
Pollyea, Daniel A.
Donnellan, Will
Fathi, Amir T.
Pigneux, Arnaud
Erba, Harry P.
Prince, Gabrielle T.
Stein, Anthony S.
Uy, Geoffrey L.
Foran, James M.
Traer, Elie
Stuart, Robert K.
Arellano, Martha L.
Slack, James L.
Sekeres, Mikkael A.
Willekens, Christophe
Choe, Sung
Wang, Hongfang
Zhang, Vickie
Yen, Katharine E.
Kapsalis, Stephanie M.
Yang, Hua
Dai, David
Fan, Bin
Goldwasser, Meredith
Liu, Hua
Agresta, Sam
Wu, Bin
Attar, Eyal C.
Tallman, Martin S.
Stone, Richard M.
Kantarjian, Hagop M.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S204 - S205

← 1 2 3 4 5 →